FindTrial
Sign In

Exploration of the Mechanism Pathways of Ischemic Stroke

Exploration of the Mechanism Pathways of Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107074
Enrollment
Unknown
Registered
2025-08-04
Start date
2025-08-05
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Ischemic stroke group:no
healthy control:no

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. over 18 years old; 2. a definite diagnosis of acute ischemic stroke with large artery occlusion (admission within 6 hours of onset) and intracranial thrombosis confirmed by imaging (such as CT or MRI); 3. According to the ORG 10172 Trial of Acute Stroke Treatment (TOAST) classification, patients were divided into large artery atherosclerosis (LAA) group and small artery occlusion (SVO) group.

Exclusion criteria

Exclusion criteria: 1. Cardiogenic embolism (CE), other stroke of definite etiology (SOE), and stroke of unknown etiology (SUE) subtypes; 2. serious heart, liver, and kidney related diseases.

Design outcomes

Primary

MeasureTime frame
transcriptomics;metabonomics;—

Secondary

MeasureTime frame
CRP;Levels of inflammatory factors;—

Countries

China

Contacts

Public ContactLihe Yao

The First Hospital of Lanzhou University

13639317172@163.com+86 136 3931 7172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026